Global Hepatitis C Virus (HCV) Antiviral Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 150488
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 123
  • list Chemicals and Materials

Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.

Scope of the Report:

This report focuses on the Hepatitis C Virus (HCV) Antiviral in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Hepatitis C Virus (HCV) Antiviral is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Roche Diagnostics

Abbott

Siemens

Qiagen

bioMérieux

Bio-Rad Laboratories

Meridian Bioscience

Vista Diagnostics

Biogate Laboratories

J.Mitra & Co. Ltd

Siemens Medical

General Biologicals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

HCV Antibody

HCV Viral Load

HCV Genotyping

Market Segment by Applications, can be divided into

Diagnostic Centers

Hospitals

Home Use

There are 15 Chapters to deeply display the global Hepatitis C Virus (HCV) Antiviral market.

Chapter 1, to describe Hepatitis C Virus (HCV) Antiviral Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hepatitis C Virus (HCV) Antiviral, with sales, revenue, and price of Hepatitis C Virus (HCV) Antiviral, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hepatitis C Virus (HCV) Antiviral, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hepatitis C Virus (HCV) Antiviral market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hepatitis C Virus (HCV) Antiviral sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Hepatitis C Virus (HCV) Antiviral Introduction

1.2 Market Analysis by Type

1.2.1 HCV Antibody

1.2.2 HCV Viral Load

1.2.3 HCV Genotyping

1.3 Market Analysis by Applications

1.3.1 Diagnostic Centers

1.3.2 Hospitals

1.3.3 Home Use

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Roche Diagnostics

2.1.1 Business Overview

2.1.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Abbott

2.2.1 Business Overview

2.2.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Abbott Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Siemens

2.3.1 Business Overview

2.3.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Siemens Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Qiagen

2.4.1 Business Overview

2.4.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Qiagen Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 bioMérieux

2.5.1 Business Overview

2.5.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 bioMérieux Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bio-Rad Laboratories

2.6.1 Business Overview

2.6.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Meridian Bioscience

2.7.1 Business Overview

2.7.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Vista Diagnostics

2.8.1 Business Overview

2.8.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Biogate Laboratories

2.9.1 Business Overview

2.9.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 J.Mitra & Co. Ltd

2.10.1 Business Overview

2.10.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Siemens Medical

2.11.1 Business Overview

2.11.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Siemens Medical Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 General Biologicals

2.12.1 Business Overview

2.12.2 Hepatitis C Virus (HCV) Antiviral Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 General Biologicals Hepatitis C Virus (HCV) Antiviral Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Hepatitis C Virus (HCV) Antiviral Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Hepatitis C Virus (HCV) Antiviral Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Hepatitis C Virus (HCV) Antiviral Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Hepatitis C Virus (HCV) Antiviral Manufacturer Market Share in 2017

3.3.2 Top 6 Hepatitis C Virus (HCV) Antiviral Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Hepatitis C Virus (HCV) Antiviral Market Analysis by Regions

4.1 Global Hepatitis C Virus (HCV) Antiviral Sales, Revenue and Market Share by Regions

4.1.1 Global Hepatitis C Virus (HCV) Antiviral Sales and Market Share by Regions (2013-2018)

4.1.2 Global Hepatitis C Virus (HCV) Antiviral Revenue and Market Share by Regions (2013-2018)

4.2 North America Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

4.3 Europe Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

4.5 South America Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

5 North America Hepatitis C Virus (HCV) Antiviral by Countries

5.1 North America Hepatitis C Virus (HCV) Antiviral Sales, Revenue and Market Share by Countries

5.1.1 North America Hepatitis C Virus (HCV) Antiviral Sales and Market Share by Countries (2013-2018)

5.1.2 North America Hepatitis C Virus (HCV) Antiviral Revenue and Market Share by Countries (2013-2018)

5.2 United States Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

5.3 Canada Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

5.4 Mexico Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

6 Europe Hepatitis C Virus (HCV) Antiviral by Countries

6.1 Europe Hepatitis C Virus (HCV) Antiviral Sales, Revenue and Market Share by Countries

6.1.1 Europe Hepatitis C Virus (HCV) Antiviral Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Hepatitis C Virus (HCV) Antiviral Revenue and Market Share by Countries (2013-2018)

6.2 Germany Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

6.3 UK Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

6.4 France Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

6.5 Russia Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

6.6 Italy Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

7 Asia-Pacific Hepatitis C Virus (HCV) Antiviral by Countries

7.1 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Revenue and Market Share by Countries (2013-2018)

7.2 China Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

7.3 Japan Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

7.4 Korea Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

7.5 India Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

8 South America Hepatitis C Virus (HCV) Antiviral by Countries

8.1 South America Hepatitis C Virus (HCV) Antiviral Sales, Revenue and Market Share by Countries

8.1.1 South America Hepatitis C Virus (HCV) Antiviral Sales and Market Share by Countries (2013-2018)

8.1.2 South America Hepatitis C Virus (HCV) Antiviral Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

8.3 Argentina Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

8.4 Colombia Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

9 Middle East and Africa Hepatitis C Virus (HCV) Antiviral by Countries

9.1 Middle East and Africa Hepatitis C Virus (HCV) Antiviral Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Hepatitis C Virus (HCV) Antiviral Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Hepatitis C Virus (HCV) Antiviral Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

9.3 UAE Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

9.4 Egypt Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

9.5 Nigeria Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

9.6 South Africa Hepatitis C Virus (HCV) Antiviral Sales and Growth Rate (2013-2018)

10 Global Hepatitis C Virus (HCV) Antiviral Market Segment by Type

10.1 Global Hepatitis C Virus (HCV) Antiviral Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Hepatitis C Virus (HCV) Antiviral Sales and Market Share by Type (2013-2018)

10.1.2 Global Hepatitis C Virus (HCV) Antiviral Revenue and Market Share by Type (2013-2018)

10.2 HCV Antibody Sales Growth and Price

10.2.1 Global HCV Antibody Sales Growth (2013-2018)

10.2.2 Global HCV Antibody Price (2013-2018)

10.3 HCV Viral Load Sales Growth and Price

10.3.1 Global HCV Viral Load Sales Growth (2013-2018)

10.3.2 Global HCV Viral Load Price (2013-2018)

10.4 HCV Genotyping Sales Growth and Price

10.4.1 Global HCV Genotyping Sales Growth (2013-2018)

10.4.2 Global HCV Genotyping Price (2013-2018)

11 Global Hepatitis C Virus (HCV) Antiviral Market Segment by Application

11.1 Global Hepatitis C Virus (HCV) Antiviral Sales Market Share by Application (2013-2018)

11.2 Diagnostic Centers Sales Growth (2013-2018)

11.3 Hospitals Sales Growth (2013-2018)

11.4 Home Use Sales Growth (2013-2018)

12 Hepatitis C Virus (HCV) Antiviral Market Forecast (2018-2023)

12.1 Global Hepatitis C Virus (HCV) Antiviral Sales, Revenue and Growth Rate (2018-2023)

12.2 Hepatitis C Virus (HCV) Antiviral Market Forecast by Regions (2018-2023)

12.2.1 North America Hepatitis C Virus (HCV) Antiviral Market Forecast (2018-2023)

12.2.2 Europe Hepatitis C Virus (HCV) Antiviral Market Forecast (2018-2023)

12.2.3 Asia-Pacific Hepatitis C Virus (HCV) Antiviral Market Forecast (2018-2023)

12.2.4 South America Hepatitis C Virus (HCV) Antiviral Market Forecast (2018-2023)

12.2.5 Middle East and Africa Hepatitis C Virus (HCV) Antiviral Market Forecast (2018-2023)

12.3 Hepatitis C Virus (HCV) Antiviral Market Forecast by Type (2018-2023)

12.3.1 Global Hepatitis C Virus (HCV) Antiviral Sales Forecast by Type (2018-2023)

12.3.2 Global Hepatitis C Virus (HCV) Antiviral Market Share Forecast by Type (2018-2023)

12.4 Hepatitis C Virus (HCV) Antiviral Market Forecast by Application (2018-2023)

12.4.1 Global Hepatitis C Virus (HCV) Antiviral Sales Forecast by Application (2018-2023)

12.4.2 Global Hepatitis C Virus (HCV) Antiviral Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Hepatitis C Virus (HCV) Antiviral Picture

Table Product Specifications of Hepatitis C Virus (HCV) Antiviral

Figure Global Sales Market Share of Hepatitis C Virus (HC

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery